Publications from the faculty of the Department of Oral and Maxillofacial Surgery

  • Our interferon treatment protocol for giant cell tumors of the jaw experiences vastly better outcomes than conventional treatments.

Giant Cell Tumors

 

post interferon treatment

 

This 3D image shows new bone growth following elimination of a destructive jaw tumor through interferon therapy.

 

 

Susarla S, August M, Dewsnap N, Faquin WC, Kaban LB, Dodson TB. CD34 staining density predicts giant cell tumor clinical behavior.  J Oral Maxillofac Surg May 2009, 67(5) 996-1008.

 

Kaban LB, Troulis MJ, Wilkinson M, Ebb D, Dodson TB. Adjuvant antiangiogenic therapy for giant cell tumors of the jaws. J Oral Maxillofac Surg, 2008.

 

Dewsnap NC, Susarla SM, Abulikemu M, Faquin FC, Kaban LB, August M.  Immunohistochemical evaluation of giant cell tumors of the jaws using CD34 density analysis.  J. Oral Maxillofac Surg, 66:928-933, 2008.

 

Kaban LB, Dodson TB.  Discussion:  Calcitonin therapy for central giant cell granuloma.  J Oral Maxillofac Surg 61(6):653-654, 2003.

 

Kaban, LB, Troulis MJ, Ebb D, August M, Hornicek F, Dodson TB. Anti-angiogenic therapy with Interferon-alpha for giant cell lesions of the jaws. J Oral Maxillofac Surg 2002;60:103.

Return to OMS Research page

 

Patient confidentiality

Mass General places the highest priority on a patient’s right to privacy. Learn how medical information about you is used and disclosed.